Member Article

Well-known corporate finance lawyer joins Clarion

Clarion is continuing to build the expertise within its corporate team with the appointment of experienced business lawyer Laurie Dale as a legal director.

Having worked in private practice for over 20 years and subsequently in industry as general counsel and company secretary to a publicly quoted pharmaceutical company, Laurie has extensive experience in a range of sectors, with a particular focus on advising pharma and technology clients.

In his new role with Clarion, Laurie will work across the corporate practice, handling transactional matters as well as providing advisory services.

In addition, Amy Buttrick has joined the corporate team as an associate. She has experience of a variety of corporate transactional matters.

Richard Moran, senior partner and head of Clarion’s corporate team, comments: “We are committed to our long-term, strategic plan. Laurie’s appointment is an important step in helping us to further strengthen our offering in some of the industries we see as having great potential for future growth.

“Clarion has a strong track record in both technology and pharma and Laurie will help us to build on our expertise in these areas. We are pleased to welcome such an experienced corporate lawyer as well as continuing to develop young talent as Amy joins our 14-strong team.”

Laurie adds: “Joining the Clarion team is an ideal opportunity to move back into private practice and contribute my broad experience to one of the region’s leading firms. With the corporate team’s strength in depth, I am looking forward to working not only in a hands-on capacity, but also in helping the younger members of the team to progress.

“Having always enjoyed working across a wide range of corporate matters, I was attracted to the firm’s culture of embracing long-term relationships with clients, across all service offerings. In particular, the strength of the intellectual property and commercial teams greatly enhances the firm’s corporate offering to the pharma and tech sectors.”

This was posted in Bdaily's Members' News section by Emma Kilmurray .